A multicenter, open-labeled, 96-week study to investigate the safety, pharmacokinetics, and efficacy of indinavir in combination with stavudine and lamivudine [lamivudine/stavudine] in pediatric patients with HIV-1 infection
Phase of Trial: Phase I
Latest Information Update: 16 Feb 2012
At a glance
- Drugs Indinavir (Primary) ; Lamivudine/stavudine (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 20 Oct 2005 New trial record.